link to homepage

Institute of Neuroscience and Medicine

Navigation and service

Developing technologies…

To establish new therapies we implement our scientific knowledge into innovative medical devices and procedures for invasive and noninvasive neurostimulation. For a successful industrial implementation those new technologies need to be protected by letters patents.

Now we have nearly 30 international patent families declared. Several patents have already been issued, e.g. the basic CR®- patent (Europe and USA). Also we have a close cooperation with the company ANM Adaptive Neuromodulation GmbH. ANM has developed – based on our acoustic CR®-technology and in close collaboration with us – the T30CR® System for acoustic neuromodulation (i.e. the acoustic CR®-stimulation) for the treatment of tinnitus. In addition, ANM develops an implant for the treatment of Parkinson patients with electrical CR®-Neurostimulation.